8-K: Align Technology Reports Record Q2 2026 Revenue

Align Technology announced record second quarter 2026 revenues of $1.06 billion, driven by strong Clear Aligner performance, while Systems and Services revenue saw a decline.

Summary

• Align Technology reported record second quarter 2026 revenues of $1,056.2 million, a 4.3% increase year-over-year and 1.5% increase sequentially.
• Clear Aligner revenues reached a record $870.9 million, up 8.2% year-over-year, with shipments increasing 7.4% to 691.8 thousand cases.
• Imaging Systems and CAD/CAM Services revenues were $185.3 million, down 10.8% year-over-year, attributed to a soft capital equipment market and a shift towards leasing models.
• GAAP net income was $108.3 million, or $1.51 per diluted share, a decrease from the prior year.
• Non-GAAP net income was $189.1 million, or $2.64 per diluted share, an increase year-over-year.
• The company ended the quarter with $1,102.6 million in cash and cash equivalents.
• Align Technology repurchased approximately 0.4 million shares for $67.0 million during the quarter.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a mixed but generally positive report. Record revenues and strong Clear Aligner growth are positives, but the decline in Systems and Services and the UK VAT issue introduce some caution.

Positives

• Record Q2'26 revenues of $1.06 billion, up 4.3% year-over-year.
• Record Clear Aligner revenues of $870.9 million, up 8.2% year-over-year.
• Record Clear Aligner shipments of 691.8 thousand cases, up 7.4% year-over-year.
• Non-GAAP operating margin of 22.9% exceeded expectations.
• Continued double-digit growth in APAC, EMEA, and Latin America for Clear Aligners.
• Stable performance in North America for Clear Aligners.
• Non-GAAP net income per share of $2.64, up from $2.49 year-over-year.
• Strong balance sheet with over $1.1 billion in cash and cash equivalents.

Negatives

• Imaging Systems and CAD/CAM Services revenues decreased by 10.8% year-over-year.
• GAAP net income decreased by 13.1% year-over-year.
• GAAP diluted EPS decreased to $1.51 from $1.72 year-over-year.
• Foreign exchange unfavorably impacted Q2'26 GAAP and non-GAAP EPS by approximately $0.23 year-over-year.
• An estimated liability of approximately $37.5 million, inclusive of interest, was recorded related to UK VAT.

Risks

• Softness in the capital equipment market impacting Imaging Systems and CAD/CAM Services revenue.
• A shift in sales mix towards lower-priced scanners and flexible acquisition models (leasing/rental) impacting upfront revenue.
• Uncertainty regarding the ultimate resolution of the UK VAT ruling, despite an intention to appeal.
• Potential impact of foreign exchange rate fluctuations on financial results.
• Macroeconomic conditions, geopolitical events, and trade policies could disrupt supply chains and the global economy.
• Changes in customer and consumer purchasing behavior due to economic uncertainty.
• Competition from existing and new competitors, including AI-powered technologies.

Future Outlook

For Q3 2026, the company expects revenues between $1,000M and $1,020M, with Clear Aligner volume up mid-single digits year-over-year. Systems & Services revenue is expected to be down sequentially and year-over-year. GAAP Gross Margin is projected to be 67.5% to 68.5%, and GAAP Operating Margin between 13.5% and 15.0%, impacted by one-time charges. For Fiscal 2026, the company reiterates its expectation for worldwide revenue growth of 3% to 4% year-over-year. Clear Aligner volume growth is expected to be approximately 6% year-over-year. GAAP Gross Margin is expected to be 70.2% to 70.5%, and GAAP Operating Margin 15.1% to 15.6%. The company anticipates non-GAAP operating margin to be approximately 23.7% for the full year. Preliminary targets for fiscal 2027 include at least a 100 basis point increase in GAAP and non-GAAP operating margins year-over-year.

Management Comments

• "We delivered a solid second quarter with record revenues of $1.06 billion, up 4.3% year-over-year, driven by record Clear Aligner volumes of 691.8 thousand cases and 8.2% Clear Aligner revenue growth."
• "Q2'26 revenues and Clear Aligner volumes were in line with our outlook, while Clear Aligner ASPs and non-GAAP operating margin of 22.9% exceeded our expectations."
• "Our second quarter results reflect continued execution across the business. Solid Clear Aligner performance, disciplined expense management, and operational improvements supported revenue growth in-line with our outlook and non-GAAP operating margin above our expectations."
• "While Q226 Systems and Services revenue was below our original expectations, underlying scanner adoption remained healthy, and the reported lower revenues reflects lower price scanners and the transition toward lease and rental models that increase access to care by offering a broader range of purchasing options and increasing adoption of our digital scanning technology. This is a deliberate trade-off on our part."
• "As more than 23 million patients have now been treated with the Invisalign System, we believe our integrated digital platform and disciplined execution position us to support customer growth, expand adoption, and drive long-term profitable growth."
• "Our strong balance sheet and healthy free cash flow generation continue to provide flexibility to invest in innovation, support our customers, and return capital to shareholders."

Industry Context

StockSavvy.ai notes that Align Technology's performance in Q2 2026 highlights a bifurcated market. While the core Clear Aligner business shows robust growth, driven by increasing adoption and international expansion, the Imaging Systems and CAD/CAM segment is experiencing headwinds due to a softening capital equipment market and a strategic shift towards more accessible leasing and rental models. This reflects a broader trend in medtech where recurring revenue and service models are gaining prominence over upfront hardware sales, especially in uncertain economic environments.

Comparison to Industry Standards

• Align Technology's 4.3% year-over-year revenue growth in Q2 2026 is moderate compared to the high-growth rates seen in some other segments of the medical device industry, but strong for a mature product line.
• The 8.2% growth in Clear Aligner revenues outpaces the typical growth rates for many established medical device product categories.
• The 10.8% decline in Imaging Systems and CAD/CAM Services revenue is a concern, especially when compared to competitors in the dental equipment space who may be experiencing more stable or growing sales in their hardware segments.
• The non-GAAP operating margin of 22.9% is strong and generally above the industry average for many medical device companies, indicating efficient operations and pricing power in its core aligner business.

Legal Proceedings

• An estimated liability of approximately $37.5 million, inclusive of interest, has been recorded related to a UK VAT ruling that clear aligners do not qualify as VAT-exempt dental prostheses. The company intends to appeal this ruling.

Stakeholder Impact

• Shareholders: The company repurchased $67.0 million of stock, returning capital. The ongoing stock repurchase program and future margin improvement targets aim to create long-term shareholder value. The UK VAT issue could impact profitability.
• Customers (Doctors): The shift to leasing and rental models for scanners aims to increase access to care and adoption of digital scanning technology, potentially benefiting doctors by lowering upfront costs.
• Patients: Lower upfront costs for scanners and continued innovation in treatment solutions aim to expand patient access to care and improve outcomes.

Next Steps

• Align Technology will hold a conference call on July 29, 2026, to review Q2'26 results and discuss future outlook.
• The company expects to complete its $200.0 million open market repurchase plan in October 2026.
• Invoices will include UK VAT at 20% on applicable Invisalign aligners and Vivera retainers effective September 7, 2026.
• The company intends to appeal the UK VAT ruling.

Key Dates

Recommendation

The company delivered record revenues and strong growth in its core Clear Aligner business, exceeding expectations on non-GAAP operating margin. However, the decline in Imaging Systems and Services, coupled with the significant UK VAT liability and the uncertainty surrounding its appeal, introduces a degree of risk. The strategic shift to leasing models, while beneficial long-term, impacts near-term revenue recognition. Therefore, a 'hold' recommendation is appropriate pending further clarity on the UK VAT situation and sustained performance in the Systems and Services segment.

Keywords

Invisalign, Clear Aligners, iTero Scanners, Digital Orthodontics, CAD/CAM Software, Dental Technology, Financial Results, Medical Devices